Literature DB >> 24799950

Thank you CytoJournal reviewers for your 2012 and 2013 services!

Vinod B Shidham1, Richard M Demay2.   

Abstract

Year:  2014        PMID: 24799950      PMCID: PMC4007383          DOI: 10.4103/1742-6413.129186

Source DB:  PubMed          Journal:  Cytojournal        ISSN: 1742-6413            Impact factor:   2.091


× No keyword cloud information.
Cytopathology foundation thanks all 2012 and 2013 CytoJournal peer reviewers for extending their resources by devoting significant efforts and time. Contribution of high quality scientific cytopathology literature through public domain under open access (OA) charter of CytoJournal is only possible with continued dedication of this segment of academia. CytoJournal peer reviewers are critical for its continued contribution of scientific cytopathology literature to the public domain under its open access (OA) charter. CytoJournal editorial board and cytopathology foundation (CF) thank all CytoJournal peer reviewers for their devotion by extending their significant efforts, time, and resources by completing the review process of all cytojournal manuscripts in a timely manner published during 2012 [Table 1][123456789101112131415161718192021222324] and 2013 [Table 2].[25262728293031323334353637383940414243444546474849] The overall acceptance rate was 52% during 2012 and 54% during 2013. Hence, there were many more manuscripts, which were reviewed but recommended for non-acceptance. Tables 1 and 2 include all the reviewers participating in the peer-review process for all the manuscripts during this period. The reviewers for individual manuscripts are assigned from the CytoJournal core reviewer panel. The list of all the CytoJournal core reviewer panel members is updated periodically on CytoJournal home page.[50]
Table 1

2012 Cytojournal peer reviewers

Table 2

2013 Cytojournal peer reviewers

2012 Cytojournal peer reviewers 2013 Cytojournal peer reviewers We thank all the authors for their continued support by publishing with CytoJournal which provides a robust OA platform. Global dissemination of their high-value cytopathology and related scientific literature as a freely available resource all over the world without losing their hard-earned copyright has been increasingly relevant. OA charter allows all CytoJournal authors to share their copyrights in the public domain under the terms of the creative commons attribution license.[51] In addition to general public benefits with barrier free, global access to a high standard scientific cytopathology knowledge, the authors as academia enjoy wider global dissemination of their work under OA charter. This translates into higher visibility with increased downloads and impact.[525354] Although actual quality and novelty of the individual study articles are the most critical factors, the probabilities of citation with continuous referencing is facilitated with increasing ease by the web matrix. If we apply Moore's law to this phenomenon of OA on the web, it suggests an increasingly higher impact with a tremendous long-term rewards.[5556] Finally, we thank all the CytoJournal authors, readers, and supporting academia for considering CytoJournal as their OA platform for cytopathology, scientific, peer-reviewed information around the globe. Our best wishes to all CytoJournal editorial board members, reviewers, authors, and readers for ongoing, collective academic prosperity.
  50 in total

1.  Metastatic urachal carcinoma in bronchial brush cytology.

Authors:  Fatima Zahra Aly; Abeer Z Tabbarah; Lysandra Voltaggio
Journal:  Cytojournal       Date:  2013-01-31       Impact factor: 2.091

2.  Prevalence of human papilloma virus in cytological abnormalities: Association of risk factors and cytomorphological findings.

Authors:  Christo D Izaaks; Ernest J Truter; Sehaam Khan
Journal:  Cytojournal       Date:  2012-08-25       Impact factor: 2.091

3.  Metastatic colorectal adenocarcinoma in cervicovaginal cytology specimens confirmed by immunocytochemical stains on liquid base specimens: Two study cases with review of the literature.

Authors:  Muhammad Zulfiqar; Susan Liu; Dongping Shi; Shashi Madan; Suzanne Jacques; Laquita King; Vinod Shidham; Tamar Giorgadze
Journal:  Cytojournal       Date:  2013-05-20       Impact factor: 2.091

Review 4.  Pre-analytic steps for molecular testing on thyroid fine-needle aspirations: The goal of good results.

Authors:  Esther Diana Rossi; Fernando Schmitt
Journal:  Cytojournal       Date:  2013-11-28       Impact factor: 2.091

5.  Adequacy of fine-needle aspiration specimens for human papillomavirus infection molecular testing in head and neck squamous cell carcinoma.

Authors:  Ricardo R Lastra; Michelle R Pramick; Megan O Nakashima; Gregory S Weinstein; Kathleen T Montone; Virginia A Livolsi; Zubair W Baloch
Journal:  Cytojournal       Date:  2013-10-29       Impact factor: 2.091

6.  Oncocytic follicular nodules of the thyroid with or without chronic lymphocytic thyroiditis: An institutional experience.

Authors:  Sule Canberk; A Carruth Griffin; Abha Goyal; He Wang; Kathleen Montone; Virginia Livolsi; Zubair Baloch
Journal:  Cytojournal       Date:  2013-01-31       Impact factor: 2.091

7.  Endoscopic ultrasound-guided fine needle aspiration of the celiac ganglion: A diagnostic pitfall.

Authors:  Di Xia; Kidada N Gilbert-Lewis; Manoop S Bhutani; Ranjana S Nawgiri
Journal:  Cytojournal       Date:  2012-10-31       Impact factor: 2.091

8.  Metastatic hepatocellular carcinoma presenting as gynecomastia in male: A diagnostic dilema in fine needle aspiration cytology.

Authors:  Jitendra G Nasit; Birwa Shah; Manoj Shah
Journal:  Cytojournal       Date:  2012-10-23       Impact factor: 2.091

9.  Drug eluting beads on cytology smears.

Authors:  Niti Manglik; Palam Annamalai; Ranjana S Nawgiri
Journal:  Cytojournal       Date:  2012-10-23       Impact factor: 2.091

10.  Cytomorphology of giant cell tumor of bone in pleural fluid.

Authors:  Rajni Yadav; Sameer Bakhshi; Sandeep R Mathur; Tvsvgk Tilak; Geetika Singh; Venkateswaran K Iyer; Suvendu Purkait; Prashant Durgapal
Journal:  Cytojournal       Date:  2012-10-23       Impact factor: 2.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.